Granahan Investment Management - Q4 2019 holdings

$2.17 Billion is the total value of Granahan Investment Management's 182 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 15.7% .

 Value Shares↓ Weighting
LPSN BuyLIVEPERSON$93,505,000
+8.0%
2,527,168
+4.2%
4.30%
-9.7%
CSGP BuyCOSTAR CORP$90,280,000
+7.0%
150,895
+6.1%
4.15%
-10.5%
CHGG BuyCHEGG INC$87,619,000
+221.9%
2,311,232
+154.3%
4.03%
+169.2%
EHTH BuyEHEALTH INC$71,050,000
+135.9%
739,493
+64.0%
3.27%
+97.3%
PAYC BuyPAYCOM SOFTWARE$62,099,000
+29.4%
234,548
+2.4%
2.86%
+8.2%
VRTU BuyVIRTUSA CORP$60,098,000
+43.1%
1,325,795
+13.7%
2.76%
+19.7%
SPSC BuySPS COMMERCE$57,043,000
+39.1%
1,029,289
+18.2%
2.62%
+16.4%
ENPH BuyENPHASE ENERGY$56,052,000
+93.2%
2,145,105
+64.4%
2.58%
+61.6%
OSIS BuyOSI SYSTEMS$47,016,000
+21.4%
466,711
+22.4%
2.16%
+1.5%
OSW BuyONESPAWORLD HOLDINGS LTD$45,905,000
+20.7%
2,725,978
+11.3%
2.11%
+0.9%
CSOD BuyCORNERSTONE ONDEMAND$35,403,000
+24.4%
604,667
+16.5%
1.63%
+4.0%
STRA BuySTRATEGIC EDUCATION$34,104,000
+85.3%
214,625
+58.4%
1.57%
+54.9%
GLOB BuyGLOBANT SA$28,069,000
+28.5%
264,677
+10.9%
1.29%
+7.5%
EXAS BuyEXACT SCIENCES$26,188,000
+41.6%
283,175
+38.4%
1.20%
+18.4%
SPT NewSprout Social Inc Class A$21,704,0001,352,277
+100.0%
1.00%
BOOM BuyDMC GLOBAL INC$21,424,000
+49.2%
476,718
+46.0%
0.99%
+24.8%
CMCO BuyCOLUMBUS MCKINNON CORPORATION$21,058,000
+10.1%
526,060
+0.2%
0.97%
-8.0%
PS BuyPLURALSIGHT INC CLASS A$20,766,000
+28.2%
1,206,628
+25.2%
0.96%
+7.3%
ESPR BuyESPERION THERAPEUTICS$17,014,000
+200.1%
285,327
+84.5%
0.78%
+151.0%
VCTR BuyVICTORY CAPITAL CLASS A$15,411,000
+62.5%
734,893
+19.2%
0.71%
+35.8%
LXFR BuyLUXFER HOLDINGS PLC$15,108,000
+25.6%
816,230
+5.8%
0.70%
+5.0%
ZS BuyZSCALER INC$14,599,000
+697.8%
313,959
+710.9%
0.67%
+565.3%
LLNW BuyLIMELIGHT NETWORKS$14,528,000
+49.4%
3,560,868
+11.0%
0.67%
+25.0%
SSTI BuySHOTSPOTTER$13,958,000
+25.4%
547,363
+13.2%
0.64%
+4.7%
INSM BuyINSMED$13,939,000
+51.7%
583,717
+12.0%
0.64%
+26.7%
OXFD BuyOXFORD IMMUNOTEC GLOBAL PLC$13,525,000
+0.1%
814,779
+0.3%
0.62%
-16.3%
EVH BuyEVOLENT HEALTH$11,803,000
+435.5%
1,304,250
+325.5%
0.54%
+348.8%
HUBS BuyHUBSPOT$11,748,000
+36.9%
74,122
+30.9%
0.54%
+14.6%
MPAA BuyMOTOR PARTS OF AMERICA$11,618,000
+542.9%
527,389
+393.3%
0.54%
+440.4%
UPLD BuyUPLAND SOFTWARE$11,578,000
+14.0%
324,211
+11.3%
0.53%
-4.7%
PRO BuyPROS HOLDING$11,208,000
+3.1%
187,052
+2.5%
0.52%
-13.7%
CWST BuyCASELLA WASTE SYSTEMS$10,702,000
+16.1%
232,500
+8.3%
0.49%
-3.0%
VCYT BuyVERACYTE INC$10,664,000
+229.0%
381,957
+182.8%
0.49%
+175.8%
QTWO BuyQ2 HOLDINGS$10,527,000
+15.8%
129,830
+12.6%
0.48%
-3.2%
LOVE NewLOVESAC$10,488,000653,455
+100.0%
0.48%
CYRX BuyCRYOPORT$10,196,000
+86.7%
619,424
+85.5%
0.47%
+56.3%
LOPE BuyGRAND CANYON EDUCATION$9,843,000
+8.8%
102,753
+11.5%
0.45%
-9.0%
HZO BuyMARINEMAX INC$9,799,000
+8.0%
587,100
+0.2%
0.45%
-9.6%
RPD BuyRAPID7$9,656,000
+23.7%
172,364
+0.3%
0.44%
+3.5%
ONTO NewONTO INNOVATION$9,596,000262,619
+100.0%
0.44%
ENTA BuyENANTA PHARMACEUTICALS$9,223,000
+3.3%
149,293
+0.5%
0.42%
-13.6%
RUBI BuyRUBICON PROJECT INC$9,136,000
+30.9%
1,119,604
+39.7%
0.42%
+9.4%
POWI BuyPOWER INTEGRATIONS$8,622,000
+9.8%
87,166
+0.4%
0.40%
-8.1%
IOTS BuyADESTO TECHNOLOGIES$8,021,000
+94.2%
943,651
+95.5%
0.37%
+62.6%
PCRX NewPACIRA BIOSCIENCES INC$7,669,000169,291
+100.0%
0.35%
KIN BuyKINDRED BIOSCIENCES$6,478,000
+27.4%
763,899
+2.9%
0.30%
+6.4%
PSTG BuyPURE STORAGE INC$6,220,000
+32.1%
363,541
+30.8%
0.29%
+10.4%
PNTG NewPENNANT GROUP INC$6,157,000186,171
+100.0%
0.28%
IIPR BuyINNOVATIVE INDUSTRIAL PRODUCTS$5,815,000
-11.7%
76,644
+7.5%
0.27%
-26.0%
HBIO BuyHARVARD BIOSCIENCE$5,749,000
+5.5%
1,884,833
+6.4%
0.26%
-11.7%
REI BuyRING ENERGY$5,205,000
+61.9%
1,971,473
+0.6%
0.24%
+35.6%
VG BuyVONAGE HOLDINGS$5,086,000
-14.1%
686,324
+31.0%
0.23%
-28.2%
VCEL BuyVERICEL CORPORATION$4,978,000
+17.1%
286,089
+1.9%
0.23%
-2.1%
QTS BuyQTS REALTY TRUST$4,532,000
+19.5%
83,501
+13.2%
0.21%0.0%
BLFS BuyBIOLIFE SOLUTIONS$4,491,000
+0.0%
277,563
+2.8%
0.21%
-16.2%
KIDS BuyORTHOPEDIATRICS$4,295,000
+35.5%
91,394
+1.7%
0.20%
+13.8%
AUTL BuyAUTOLUS$4,028,000
+6.5%
305,158
+0.2%
0.18%
-11.1%
BGCP BuyBGC PARTNERS INC$3,964,000
+58.6%
667,411
+46.9%
0.18%
+31.9%
TWLO BuyTWILIO$3,938,000
-9.3%
40,074
+1.5%
0.18%
-24.3%
NTNX BuyNUTANIX$3,664,000
+19.5%
117,197
+0.3%
0.17%0.0%
STNG BuySCORPIO TANKERS$3,502,000
+82.7%
89,017
+38.2%
0.16%
+53.3%
CTG BuyCOMPUTER TASK GROUP$3,345,000
+17.0%
645,729
+12.9%
0.15%
-1.9%
TW NewTRADEWEB MARKETS INC$3,306,00071,322
+100.0%
0.15%
BFAM BuyBRIGHT HORIZONS$3,289,000
+40.4%
21,886
+42.5%
0.15%
+17.1%
FREQ NewFREQUENCY THERAPEUTICS$2,963,000169,006
+100.0%
0.14%
PRTK BuyPARATEK PHARMACEUTICALS$2,870,000
+273.7%
712,095
+300.3%
0.13%
+214.3%
LQDT BuyLIQUIDITY SERVICES$2,615,000
+7.3%
438,772
+33.2%
0.12%
-10.4%
CTSO BuyCYTOSORBENTS CORPORATION$2,613,000
-21.8%
678,618
+2.1%
0.12%
-34.8%
PTC BuyPTC INC$2,579,000
+16.1%
34,439
+5.7%
0.12%
-2.5%
NEWR BuyNEW RELIC$2,495,000
+40.7%
37,969
+31.6%
0.12%
+17.3%
MGNX BuyMACROGENICS$2,458,000
-14.1%
225,951
+0.8%
0.11%
-28.0%
SOHO BuySOTHERLY HOTELS$2,386,000
+11.3%
351,858
+9.8%
0.11%
-6.8%
FLDM BuyFLUIDIGM CORP$2,386,000
-13.7%
685,744
+14.9%
0.11%
-27.6%
PRLB BuyPROTO LABS$2,325,000
+0.7%
22,898
+1.3%
0.11%
-15.7%
QTRX BuyQUANTERIX CORPORATION$2,332,000
+11.9%
98,682
+4.0%
0.11%
-7.0%
PFIE BuyPROFIRE ENERGY$2,035,000
-13.4%
1,403,731
+12.9%
0.09%
-27.1%
PFPT BuyPROOFPOINT$2,002,000
-8.0%
17,446
+3.5%
0.09%
-23.3%
AKAM BuyAKAMAI$1,815,000
-4.1%
21,016
+1.4%
0.08%
-19.2%
CSTL NewCASTLE BIOSCIENCES$1,817,00052,863
+100.0%
0.08%
CDTX BuyCIDARA THERAPEUTICS$1,805,000
+94.9%
470,120
+1.3%
0.08%
+62.7%
CLAR BuyCLARUS CORPORATION$1,728,000
+16.0%
127,437
+0.3%
0.08%
-2.4%
RMBL BuyRumbleOn Inc. Class B RESTRICT$1,715,000
-71.4%
2,077,530
+0.1%
0.08%
-76.1%
EDIT BuyEDITAS MEDICINE$1,639,000
+31.0%
55,345
+0.6%
0.08%
+8.7%
SPRO BuySPERO THERAPEUTICS$1,431,000
-8.5%
148,867
+0.9%
0.07%
-23.3%
XENE BuyXENON PHARMACEUTICALS$1,401,000
+46.1%
106,839
+0.4%
0.06%
+20.8%
CIEN NewCIENA$1,386,00032,475
+100.0%
0.06%
CTMX BuyCYTOMX THERAPEUTICS$1,278,000
+12.9%
153,818
+0.3%
0.06%
-4.8%
SHSP BuySHARPSPRING$1,260,000
+118.8%
109,876
+85.2%
0.06%
+81.2%
ORGO NewOrganogenesis Holdings Inc$1,203,000250,000
+100.0%
0.06%
ITRM BuyITERUM THERAPEUTICS$1,100,000
-21.3%
244,467
+0.9%
0.05%
-33.8%
NTLA BuyINTELLIA THERAPEUTICS$882,000
+10.7%
60,107
+0.7%
0.04%
-6.8%
AAN NewAARON'S INC.$898,00015,717
+100.0%
0.04%
VRNS NewVARONIS SYSTEMS$877,00011,282
+100.0%
0.04%
SGMO BuySANGAMO BIOSCIENCES$859,000
-6.6%
102,635
+1.0%
0.04%
-21.6%
ETTX BuyENTASIS THERAPEUTICS HOLDINGS$780,000
-7.1%
156,944
+11.3%
0.04%
-21.7%
DDOG NewDATA DOG INC CLASS A$735,00019,464
+100.0%
0.03%
TACT BuyTRANSACT TECHNOLOGIES INC$454,000
+3.9%
41,399
+15.1%
0.02%
-12.5%
RP BuyREALPAGE$386,000
+24.9%
7,185
+46.2%
0.02%
+5.9%
TTOO BuyT2 BIOSYSTEMS$374,000
-31.2%
319,592
+46.8%
0.02%
-43.3%
ZAGG NewZAGG INC$340,00041,965
+100.0%
0.02%
BuyNABRIVA THERAPEUTICS PLC$352,000
-25.4%
266,384
+12.9%
0.02%
-38.5%
ANGI BuyANGI HOME SERVICES$207,000
+19.7%
24,464
+0.0%
0.01%0.0%
MLNTQ BuyMELINTA THERAPEUTICS$128,000
-86.0%
241,853
+0.4%
0.01%
-88.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

About Granahan Investment Management

Granahan Investment Management is a Boston-based investment firm that specializes in small-cap growth equity strategies. The firm was founded in 1985 by Jane Granahan and her late husband, Gerald Granahan, who was a pioneer in the small-cap growth investing space. Today, the firm is led by CEO and Chief Investment Officer Gary Hatton, who has been with the firm since 1993.

Granahan Investment Management has a team of experienced investment professionals who conduct extensive research to identify high-growth companies with strong fundamentals and attractive valuations. The firm's investment process is focused on bottom-up stock selection, with a long-term investment horizon. The team seeks to invest in companies with sustainable competitive advantages, strong management teams, and attractive growth prospects.

The firm manages several mutual funds, including the Granahan Small Cap Advantage Fund, which has a 5-star Morningstar rating and has outperformed its benchmark over the long term. The firm also manages separate accounts for institutional clients.

Granahan Investment Management has a strong culture of integrity, teamwork, and client service. The firm's investment professionals are committed to delivering superior investment results and building long-term relationships with their clients.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COSTAR GROUP INC42Q3 20234.7%
SPS COMM INC42Q3 20233.5%
EURONET WORLDWIDE, INC42Q3 20231.7%
OSI SYSTEMS INC42Q3 20232.4%
RBC BEARINGS INC42Q3 20231.5%
DOUGLAS DYNAMICS INC42Q3 20231.0%
PROS HOLDINGS INC42Q3 20230.8%
RADWARE LTD42Q3 20231.3%
RUSH ENTERPRISES INC42Q3 20231.1%
POWER INTEGRATIONS INC42Q3 20230.9%

View Granahan Investment Management's complete holdings history.

Latest significant ownerships (13-D/G)
Granahan Investment Management Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Evolent Health, Inc.February 14, 20233,155,2113.1%
SHOTSPOTTER, INCFebruary 14, 2023552,6254.5%
ALTA EQUIPMENT GROUP INC.February 14, 20221,453,5474.5%
CF Finance Acquisition Corp.Sold outFebruary 14, 202200.0%
Cricut, Inc.February 14, 20221,779,1274.9%
NAUTILUS, INC.Sold outFebruary 14, 202200.0%
ONESPAWORLD HOLDINGS LtdFebruary 14, 20222,978,8074.0%
Victory Capital Holdings, Inc.February 14, 2022879,6081.3%
dMY Technology Group, Inc. IISold outMay 11, 202100.0%
RumbleON, Inc.January 21, 202140,8771.9%

View Granahan Investment Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-04-11
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Granahan Investment Management's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2173220000.0 != 2173215000.0)

Export Granahan Investment Management's holdings